Timeliness of Postmarket Studies for New Pharmaceuticals Approved Between 2009 and 2012: a Cross-Sectional Analysis

Authors

Joshua D. Wallach, Yale University
Alexander C. Egilman, Yale School of Medicine
Joseph S. Ross, Yale-New Haven Hospital
Steven Woloshin, The Dartmouth Institute for Health Policy and Clinical Practice
Lisa M. Schwartz, The Dartmouth Institute for Health Policy and Clinical Practice

Document Type

Journal Article

Publication Date

4-15-2019

Journal

Journal of General Internal Medicine

Volume

34

Issue

4

DOI

10.1007/s11606-018-4779-x

Recommended Citation

Wallach, Joshua D.; Egilman, Alexander C.; Ross, Joseph S.; Woloshin, Steven; and Schwartz, Lisa M., "Timeliness of Postmarket Studies for New Pharmaceuticals Approved Between 2009 and 2012: a Cross-Sectional Analysis" (2019). Biomedical Laboratory Sciences Faculty Publications. Paper 18.
https://hsrc.himmelfarb.gwu.edu/smhs_biomed_facupubs/18